Blocking TGF-β signal transduction with TGF-β-blocking antibodies or TGF-β receptor I kinase inhibitors can enhance anti-tumor immunity and show therapeutic benefits (Tauriello et al., 2018). The gene discussed is TGFB1; the disease is neoplasm.